SG Americas Securities’s ResMed RMD Stock Holding History

SG Americas Securities’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-30,000	Closed	-$3K	–	2801
2014 Q2	$3K	Buy	+30,000	New	+$1.49M	﹤0.01%	2486

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SG Americas Securities's RMD Position: Q1 2026 in Review

SG Americas Securities increased its ResMed (RMD) stake by 111% in Q1 2026, buying an estimated $12.8M and bringing the position to 97,275 shares worth $21.8M. The position accounts for 0.02% of the portfolio, ranked #509.

SG Americas Securities first reported a position in RMD in Q2 2013 and has held it in 51 quarters since. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

SG Americas Securities held 97,275 shares of ResMed worth $21.8M as of Q1 2026.
SG Americas Securities bought 51,201 ResMed shares in Q1 2026, an estimated $12.8M.
ResMed made up 0.02% of SG Americas Securities's portfolio in Q1 2026, its #509 holding.
SG Americas Securities first reported a position in ResMed in Q2 2013 and has held it in 51 quarters since.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.